SPOTLIGHT -
Slideshow
Author(s):
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Rural Realities: Resilience and Revelations From a Year in Psychiatry
Treating ‘Morally Objectionable’ Patients
Schizophrenia in 2025: The Dawn of a New Era?
What Will the Future of Alzheimer Disease Treatment Look Like?
Disappointing Data From Phase III CONNEX for Iclepertin in Addressing Cognition Impairment in Schizophrenia
Biomarkers for Concussion: Current Insights and Future Directions